Actonel
side effects, nutrient depletions, herbal interactions and health notes:
Data provided by Applied Health
• Calcium supplementation may affect the absorption of this medication. Conversely, people being treated with this medication may have low calcium blood levels. Check with your physician or pharmacist prior to taking supplements containing calcium or vitamin D and, if taking, make sure to take the supplement at least two hours prior to or after taking this medication.1
• Taking any antacid containing calcium or magnesium may also affect the absorption of this medication and should be separated by at least two hours prior or after the taking of this medication.2
• As many foods also contain high levels of minerals, taking this medication at the same time may reduce the absorption of the medication. Separate the taking of this medication from your food intake, according to the advice of your physician or pharmacist.3
• Magnesium, zinc, iron and other trace minerals may affect the absorption of this medication. When taking this or other medications, it is wise to consult your physician or pharmacist about your supplements and to separate the taking of all supplements at least two hours prior or after taking the medication.4
• Herbs containing high levels of certain minerals may affect the absorption of this medication. Ask your pharmacist if your herbal supplements may interact with this medication.5
References1 Reasner CA, Stone MD, Hosking DJ, et al. Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate. J Clin Endocrinol Metab 1993;77:1067-71
1 Sifton DW, ed. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc., 2000, 2504-6.
2 Reasner CA, Stone MD, Hosking DJ, et al. Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate. J Clin Endocrinol Metab 1993;77:1067-71.
2 Sifton DW, ed. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc., 2000, 2504-6.
3 Reasner CA, Stone MD, Hosking DJ, et al. Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate. J Clin Endocrinol Metab 1993;77:1067-71.
3 Sifton DW, ed. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc., 2000, 2504-6.
4 Sifton DW, ed. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc. 2000, 2504-6.
5 Sifton DW, ed. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc. 2000, 2504-6.
|
 Want more special reports like this e-mailed to you when they're available? Click here for free e-mail alerts.
Share this Special Report by linking to it
Copy and paste the following HTML code into any web page:
Disclaimers
The information in Drug Watch is provided as a courtesy to NewsTarget readers by Applied Health Solutions in cooperation with Healthway Solutions. Although the information is presented with scientific references, we do not wish to imply that this represents a comprehensive list of considerations about any specific drug, herb or nutrient. Nor should this information be considered a substitute for the advice of your doctor, pharmacist, or other healthcare practitioner. Please read the disclaimer about the intentions and limitations of the information provided on these pages. It is important to tell your doctor and pharmacist about all other drugs and nutritional supplements that you are taking if they are recommending a new medication. Copyright © 2007 by Applied Health Solutions, Inc. All rights reserved.
|
